Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies
NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC
Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects
Controlling Diabetes May Cut Liver Cancer Risk, Study Finds
Colorectal Cancer Screening Practices Need Improvement, CDC Practice Study Finds
Healthcare Utilization Figures More Than Biology In Disparity
Phase III Lung and Pancreatic Cancer Trials Are Stopped
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored
